Articles from Adverse Event Reporting News (February 26, 2007)

Title	Author	Type	Words
Congress criticizes FDA drug safety oversight.		Brief article	284
Diarrhea vaccine may cause intestinal twisting in infants.			425
EC issues Vol. 9A guidance on pharmacovigilance.	Mashaw, Rebecca	Editorial	1021
FDA asks Genentech to strengthen label warning for Xolair.			372
FDA directs ADHD drug manufacturers to notify patients about adverse events.			521
FDA issues safety alert that diabetes drug is linked to fractures in females.		Brief article	146
FDA. Baxter warn of medication mix-up.		Brief article	260
Former critics help Congress to strengthen FDA's drug safety.			403
Health Canada cites possible link between treatment-resistant HIV and anti-viral drug.		Brief article	253
Majority of drug-coated stent use not approved by FDA.			545
Pharma expanding post-market surveillance, says PwC report.			315
Revisions to Ketek labeling announced.		Brief article	186
Risk management systems, risk minimization plans set up.			1842
RLS drug linked to compulsive gambling.			629
Two-thirds of patients require medical care after cervical cancer vaccination.			313
Volume 9A establishes records inspections of adverse events.			707
Wyeth wins HRT case.		Brief article	243